An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...] …
Articles by : William Newton, Associate Editor/Senior Writer
The New Hampshire House cleared a bill last week to prohibit certain 340B-specific pharmacy benefit manager (PBM) and health insurer [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new political action committee (PAC) targeting Republican lawmakers that support 340B legislation spent $400,000 in a key West Virginia [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
On the final day of Missouri’s legislative session, lawmakers overwhelmingly passed a bill to bar drugmaker 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
This week will see major legislative action on up to four state 340B contract pharmacy access bills—including on two controversial [...] …